← Back to Search

Behavioural Intervention

Leg Heat Therapy for Peripheral Arterial Disease

N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men and women older than 60 years
Be older than 18 years old
Must not have
Prior foot or leg amputation
Critical limb ischemia (ischemic rest pain or ischemia-related, non-healing wounds or tissue loss)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial will evaluate the effects of leg heat therapy on lower-extremity functioning and quality of life in patients with PAD. 106 patients will be randomized to either leg HT or a sham intervention. Outcomes will be monitored for 12 weeks.

Who is the study for?
This trial is for men and women over 60 with lower-extremity peripheral artery disease (PAD), evidenced by a low ankle-brachial index. It's not for those with critical limb ischemia, other conditions limiting exercise tolerance, recent leg surgeries, use of walking aids besides a cane, severe kidney disease or obesity, inability to wear water-circulating trousers, certain mental impairments or thermal sensation issues in the legs.
What is being tested?
The study tests if home-based leg heat therapy improves walking ability and quality of life in PAD patients compared to a sham control. Participants are randomly assigned to either real heat treatment or fake (sham) intervention and followed up after 12 weeks to measure changes in walk distance and various health scores.
What are the potential side effects?
Potential side effects may include discomfort from the heat application or skin irritation under the water-circulating trousers used for therapy. Since it's non-invasive, serious side effects are unlikely but monitoring will occur for any unexpected reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 60 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a foot or leg amputation.
Select...
I have severe leg pain at rest or wounds that won't heal due to poor blood flow.
Select...
My kidney function is severely reduced.
Select...
I use a walking aid that is not a cane.
Select...
I can't have an MRI due to certain medical devices or conditions.
Select...
My BMI is 35 or higher.
Select...
I cannot fit into water-circulating trousers.
Select...
My cancer is currently active.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in 6-minute walk distance
Secondary study objectives
Change in Short Physical Performance Battery (SPPB) score
Change in Short-Form (SF)-36 Questionnaire score
Change in Walking Impairment Questionnaire (WIQ) score
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Heat therapyExperimental Treatment1 Intervention
Patients will be provided with water-circulating trousers, a water heater, and a water tank coupled to a water pump. The heater will be adjusted to warm up the water to 42ºC. Participants will be asked to apply the therapy daily for 90 min while seated or in the supine position.
Group II: Sham ControlActive Control1 Intervention
Patients will be provided with water-circulating trousers, a water heater, and a water tank coupled to a water pump. The heater will be adjusted to warm up the water to 33ºC. Participants will be asked to apply the therapy daily for 90 min while seated or in the supine position.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
1,039 Previous Clinical Trials
1,218,952 Total Patients Enrolled
6 Trials studying Peripheral Arterial Disease
175 Patients Enrolled for Peripheral Arterial Disease
Purdue UniversityOTHER
233 Previous Clinical Trials
71,272 Total Patients Enrolled
2 Trials studying Peripheral Arterial Disease
6 Patients Enrolled for Peripheral Arterial Disease
National Institute on Aging (NIA)NIH
1,789 Previous Clinical Trials
28,188,226 Total Patients Enrolled
22 Trials studying Peripheral Arterial Disease
24,489 Patients Enrolled for Peripheral Arterial Disease

Media Library

Leg Heat Therapy (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05465070 — N/A
Peripheral Arterial Disease Research Study Groups: Heat therapy, Sham Control
Peripheral Arterial Disease Clinical Trial 2023: Leg Heat Therapy Highlights & Side Effects. Trial Name: NCT05465070 — N/A
Leg Heat Therapy (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05465070 — N/A
~54 spots leftby Dec 2026